Biotech

A U.S. District court in Wisconsin has issued an injunction to enjoin Abbott Laboratories from any further sales of products that infringe on a patent held by Innogenetics, a Belgian-based biopharmaceutical firm. It is the latest in a series of court victories for Innogenetics,...

The Democratic Party now controls both houses of Congress, and it was reflected in a strong vote in the House of Representatives in favor of lifting President Bush's restrictions on federal funding for embryonic stem cell research. The vote, however, was still well short of...

Governor Jim Doyle has sent a letter to all members of Wisconsin's Congressional delegation urging them to vote to lift president George W. Bush's restrictions on embryonic stem cell research and pass the Stem Cell Research Enhancement Act of 2007. The legislation would lift current...

BioSystem Development, a Middleton biotech firm that has developed a new system for protein analysis, will receive more than $700,000 in equity funding from two Wisconsin angel investment groups....

Mirus Bio, a Madison biotechnology company, has entered into a milestone agreement with pharmaceutical giant Pfizer to develop gene suppression techniques for the development of drugs. The agreement will enable Mirus to further develop two platform technologies used to deliver nucleic acid to the bloodstream...

NimbleGen, a Madison biotechnology company that manufactures microarrays for use in scientific research, has entered into a commercial relationship with a British company that also develops microarrays....

Michael J. Dunn will step down as executive vice president and dean of the Medical College of Wisconsin, a position he has held for the past 12 years. He will become a distinguished professor in the Medical College's Department of Medicine once a replacement is...

Corporate officers and directors have been found personally liable for IP infringement if they intentionally, actively, and knowingly assist in the corporation's infringement. To minimize those risks, Madison attorney Gina Carter, in this inaugural edition of IP Law, explains the circumstances and scenarios that lead...